Affimed (AFMD) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free AFMD Stock Alerts $5.63 +0.28 (+5.23%) (As of 08:38 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAffimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncologyglobenewswire.com - April 24 at 4:05 AMAffimed (NASDAQ:AFMD) Stock Crosses Below 50-Day Moving Average of $5.54americanbankingnews.com - April 23 at 5:20 AMAffimed (NASDAQ:AFMD) Sees Large Increase in Short Interestamericanbankingnews.com - April 14 at 4:16 AMAffimed (NASDAQ:AFMD) Receives Average Recommendation of "Buy" from Brokeragesmarketbeat.com - April 11 at 2:30 AMFY2024 EPS Estimates for Affimed (NASDAQ:AFMD) Lifted by Cantor Fitzgeraldmarketbeat.com - April 4 at 9:14 AMAffimed (NASDAQ:AFMD) Expected to Earn FY2028 Earnings of ($0.92) Per Sharemarketbeat.com - April 3 at 6:46 AMPromising Clinical Trials and Strategic Financial Management Affirm Buy Rating for Affimedmarkets.businessinsider.com - April 1 at 3:32 PMAffimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 3:32 PMAffimed (NASDAQ:AFMD) Price Target Cut to $25.00marketbeat.com - April 1 at 12:23 PMAffimed's (AFMD) "Overweight" Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - April 1 at 12:23 PMShort Interest in Affimed (NASDAQ:AFMD) Grows By 10.6%marketbeat.com - April 1 at 3:36 AMBuy Rating Affirmed on Affimed: Promising Clinical Outlook and Robust Financial Positionmarkets.businessinsider.com - March 31 at 3:31 PMQ4 2023 Affimed NV Earnings Call Transcriptgurufocus.com - March 31 at 9:01 AMHere's what Wall Street expects from Affimed's earningsmarkets.businessinsider.com - March 28 at 4:30 PMAFMD Stock Earnings: Affimed Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 28 at 12:16 PMAffimed Reports 2023 Financial Results and Operational Progressglobenewswire.com - March 28 at 6:30 AMA Preview Of Affimed's Earningsbenzinga.com - March 27 at 1:34 PMAffimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024globenewswire.com - March 21 at 6:30 AMAffimed (AFMD) Scheduled to Post Earnings on Thursdaymarketbeat.com - March 20 at 7:46 AMJefferies starts Cue at buy, cites partnering potentialseekingalpha.com - March 13 at 7:01 PMAffimed (NASDAQ:AFMD) Sees Strong Trading Volumemarketbeat.com - March 12 at 11:45 AMAffimed (NASDAQ:AFMD) Short Interest Updatemarketbeat.com - March 12 at 9:41 AMmarketbeat.com - March 11 at 6:10 AMWhy Is Affimed (AFMD) Stock Moving Today?msn.com - March 8 at 8:48 AMWhy Is Affimed (AFMD) Stock Moving Today?investorplace.com - March 8 at 8:37 AMVaxxinity gains after early-stage data for Parkinson’s disease drugmsn.com - March 7 at 8:25 PMAffimed N.V.: Affimed Announces 1-for-10 Reverse Stock Splitfinanznachrichten.de - March 6 at 5:25 PMAffimed falls on 1-for-10 reverse stock splitmsn.com - March 6 at 5:25 PM7 of the Best Speculative Stocks You Can Snag for Less Than $1investorplace.com - March 6 at 3:36 PMAffimed Announces 1-for-10 Reverse Stock Splitglobenewswire.com - March 6 at 6:30 AMAffimed (NASDAQ:AFMD) Sees Large Decrease in Short Interestmarketbeat.com - February 14 at 11:59 AMAffimed (NASDAQ:AFMD) Shares Pass Above 50 Day Moving Average of $0.53marketbeat.com - February 14 at 4:39 AMAffimed (NASDAQ:AFMD) Stock Passes Above Fifty Day Moving Average of $0.52marketbeat.com - February 6 at 4:38 AMAffimed CEO Adi Hoess Steps Down; Co to Cut Up to 50% of Workforcemarketwatch.com - January 9 at 11:55 AMAffimed N.V.: Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancerfinanznachrichten.de - January 9 at 6:55 AMAffimed N.V. to Expand Cohort in Study of AFM24 Following Promising Datamarketwatch.com - January 8 at 5:34 PMAffimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancerfinance.yahoo.com - January 8 at 5:34 PMAffimed Announces Leadership Change and Organizational Restructuringfinance.yahoo.com - January 8 at 12:34 PMAffimed N.V.: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheckfinanznachrichten.de - January 3 at 10:35 AMAffimed Announces Sale of Wholly-Owned Subsidiary AbCheckfinance.yahoo.com - January 3 at 10:35 AMBuy Rating Reaffirmed for Affimed as Promising Clinical Trials Propel Optimismmarkets.businessinsider.com - December 14 at 11:46 PMAffimed erases gains despite positive trial datamsn.com - December 11 at 1:31 PMAffimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24finance.yahoo.com - December 4 at 7:42 AMAffimed slips as finance chief and science chief departmsn.com - November 30 at 6:15 PMPromising Investment Potential in Affimed’s Stock: Harnessing Clinical Trials for Lymphoma Treatment and FDA Meeting Resolutionmarkets.businessinsider.com - November 20 at 3:35 PMAffimed N.V. (NASDAQ:AFMD) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 20 at 10:24 AMTruist Financial Reaffirms Their Buy Rating on Affimed (AFMD)markets.businessinsider.com - November 17 at 6:34 PMAnalysts Are Bullish on Top Healthcare Stocks: Syros Pharmaceuticals (SYRS), Affimed (AFMD)markets.businessinsider.com - November 15 at 1:56 PMAffimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progressfinance.yahoo.com - November 14 at 10:02 AMRecap: Affimed Q3 Earningsbenzinga.com - November 14 at 10:02 AM Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry AFMD Media Mentions By Week AFMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AFMD News Sentiment▼-0.200.44▲Average Medical News Sentiment AFMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AFMD Articles This Week▼22▲AFMD Articles Average Week Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LPTX News Today ALRN News Today LFVN News Today CMRX News Today IFRX News Today ONCY News Today MRNS News Today ETON News Today RVPH News Today SPRO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AFMD) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affimed Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
